Global Cell Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cell Therapy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Autologous
  • 1.4.3 Allogeneic
• 1.5 Market by Application
  • 1.5.1 Global Cell Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and clinics
  • 1.5.3 ASCs
  • 1.5.4 Regenerative medicine centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cell Therapy Market Perspective (2015-2026)
• 2.2 Global Cell Therapy Growth Trends by Regions
  • 2.2.1 Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cell Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cell Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cell Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cell Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cell Therapy Players by Market Size
  • 3.1.1 Global Top Cell Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Cell Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cell Therapy Market Concentration Ratio
  • 3.2.1 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cell Therapy Revenue in 2019
• 3.3 Cell Therapy Key Players Head office and Area Served
• 3.4 Key Players Cell Therapy Product Solution and Service
• 3.5 Date of Enter into Cell Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cell Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cell Therapy Market Size by Application (2015-2020)
• 5.2 Global Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cell Therapy Market Size (2015-2020)
• 6.2 Cell Therapy Key Players in North America (2019-2020)
• 6.3 North America Cell Therapy Market Size by Type (2015-2020)
• 6.4 North America Cell Therapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cell Therapy Market Size (2015-2020)
• 7.2 Cell Therapy Key Players in Europe (2019-2020)
• 7.3 Europe Cell Therapy Market Size by Type (2015-2020)
• 7.4 Europe Cell Therapy Market Size by Application (2015-2020)

8 China

• 8.1 China Cell Therapy Market Size (2015-2020)
• 8.2 Cell Therapy Key Players in China (2019-2020)
• 8.3 China Cell Therapy Market Size by Type (2015-2020)
• 8.4 China Cell Therapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cell Therapy Market Size (2015-2020)
• 9.2 Cell Therapy Key Players in Japan (2019-2020)
• 9.3 Japan Cell Therapy Market Size by Type (2015-2020)
• 9.4 Japan Cell Therapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cell Therapy Market Size (2015-2020)
• 10.2 Cell Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cell Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cell Therapy Market Size by Application (2015-2020)

11 India

• 11.1 India Cell Therapy Market Size (2015-2020)
• 11.2 Cell Therapy Key Players in India (2019-2020)
• 11.3 India Cell Therapy Market Size by Type (2015-2020)
• 11.4 India Cell Therapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cell Therapy Market Size (2015-2020)
• 12.2 Cell Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cell Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America Cell Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Dendreon
  • 13.1.1 Dendreon Company Details
  • 13.1.2 Dendreon Business Overview
  • 13.1.3 Dendreon Cell Therapy Introduction
  • 13.1.4 Dendreon Revenue in Cell Therapy Business (2015-2020))
  • 13.1.5 Dendreon Recent Development
• 13.2 Mesoblast
  • 13.2.1 Mesoblast Company Details
  • 13.2.2 Mesoblast Business Overview
  • 13.2.3 Mesoblast Cell Therapy Introduction
  • 13.2.4 Mesoblast Revenue in Cell Therapy Business (2015-2020)
  • 13.2.5 Mesoblast Recent Development
• 13.3 Vericel
  • 13.3.1 Vericel Company Details
  • 13.3.2 Vericel Business Overview
  • 13.3.3 Vericel Cell Therapy Introduction
  • 13.3.4 Vericel Revenue in Cell Therapy Business (2015-2020)
  • 13.3.5 Vericel Recent Development
• 13.4 Novartis AG
  • 13.4.1 Novartis AG Company Details
  • 13.4.2 Novartis AG Business Overview
  • 13.4.3 Novartis AG Cell Therapy Introduction
  • 13.4.4 Novartis AG Revenue in Cell Therapy Business (2015-2020)
  • 13.4.5 Novartis AG Recent Development
• 13.5 GlaxoSmithKline plc
  • 13.5.1 GlaxoSmithKline plc Company Details
  • 13.5.2 GlaxoSmithKline plc Business Overview
  • 13.5.3 GlaxoSmithKline plc Cell Therapy Introduction
  • 13.5.4 GlaxoSmithKline plc Revenue in Cell Therapy Business (2015-2020)
  • 13.5.5 GlaxoSmithKline plc Recent Development
• 13.6 MEDIPOST
  • 13.6.1 MEDIPOST Company Details
  • 13.6.2 MEDIPOST Business Overview
  • 13.6.3 MEDIPOST Cell Therapy Introduction
  • 13.6.4 MEDIPOST Revenue in Cell Therapy Business (2015-2020)
  • 13.6.5 MEDIPOST Recent Development
• 13.7 Osiris
  • 13.7.1 Osiris Company Details
  • 13.7.2 Osiris Business Overview
  • 13.7.3 Osiris Cell Therapy Introduction
  • 13.7.4 Osiris Revenue in Cell Therapy Business (2015-2020)
  • 13.7.5 Osiris Recent Development
• 13.8 PHARMICELL
  • 13.8.1 PHARMICELL Company Details
  • 13.8.2 PHARMICELL Business Overview
  • 13.8.3 PHARMICELL Cell Therapy Introduction
  • 13.8.4 PHARMICELL Revenue in Cell Therapy Business (2015-2020)
  • 13.8.5 PHARMICELL Recent Development
• 13.9 NuVasive, Inc.
  • 13.9.1 NuVasive, Inc. Company Details
  • 13.9.2 NuVasive, Inc. Business Overview
  • 13.9.3 NuVasive, Inc. Cell Therapy Introduction
  • 13.9.4 NuVasive, Inc. Revenue in Cell Therapy Business (2015-2020)
  • 13.9.5 NuVasive, Inc. Recent Development
• 13.10 JCR Pharmaceuticals Co., Ltd
  • 13.10.1 JCR Pharmaceuticals Co., Ltd Company Details
  • 13.10.2 JCR Pharmaceuticals Co., Ltd Business Overview
  • 13.10.3 JCR Pharmaceuticals Co., Ltd Cell Therapy Introduction
  • 13.10.4 JCR Pharmaceuticals Co., Ltd Revenue in Cell Therapy Business (2015-2020)
  • 13.10.5 JCR Pharmaceuticals Co., Ltd Recent Development
• 13.11 ANTEROGEN.CO.,LTD.
  • 10.11.1 ANTEROGEN.CO.,LTD. Company Details
  • 10.11.2 ANTEROGEN.CO.,LTD. Business Overview
  • 10.11.3 ANTEROGEN.CO.,LTD. Cell Therapy Introduction
  • 10.11.4 ANTEROGEN.CO.,LTD. Revenue in Cell Therapy Business (2015-2020)
  • 10.11.5 ANTEROGEN.CO.,LTD. Recent Development
• 13.12 Cynata
  • 10.12.1 Cynata Company Details
  • 10.12.2 Cynata Business Overview
  • 10.12.3 Cynata Cell Therapy Introduction
  • 10.12.4 Cynata Revenue in Cell Therapy Business (2015-2020)
  • 10.12.5 Cynata Recent Development
• 13.13 CELLECTIS
  • 10.13.1 CELLECTIS Company Details
  • 10.13.2 CELLECTIS Business Overview
  • 10.13.3 CELLECTIS Cell Therapy Introduction
  • 10.13.4 CELLECTIS Revenue in Cell Therapy Business (2015-2020)
  • 10.13.5 CELLECTIS Recent Development
• 13.14 BioNTech IMFS
  • 10.14.1 BioNTech IMFS Company Details
  • 10.14.2 BioNTech IMFS Business Overview
  • 10.14.3 BioNTech IMFS Cell Therapy Introduction
  • 10.14.4 BioNTech IMFS Revenue in Cell Therapy Business (2015-2020)
  • 10.14.5 BioNTech IMFS Recent Development
• 13.15 EUFETS GmbH
  • 10.15.1 EUFETS GmbH Company Details
  • 10.15.2 EUFETS GmbH Business Overview
  • 10.15.3 EUFETS GmbH Cell Therapy Introduction
  • 10.15.4 EUFETS GmbH Revenue in Cell Therapy Business (2015-2020)
  • 10.15.5 EUFETS GmbH Recent Development
• 13.16 Cognate
  • 10.16.1 Cognate Company Details
  • 10.16.2 Cognate Business Overview
  • 10.16.3 Cognate Cell Therapy Introduction
  • 10.16.4 Cognate Revenue in Cell Therapy Business (2015-2020)
  • 10.16.5 Cognate Recent Development
• 13.17 Pluristem
  • 10.17.1 Pluristem Company Details
  • 10.17.2 Pluristem Business Overview
  • 10.17.3 Pluristem Cell Therapy Introduction
  • 10.17.4 Pluristem Revenue in Cell Therapy Business (2015-2020)
  • 10.17.5 Pluristem Recent Development
• 13.18 Grupo Praxis
  • 10.18.1 Grupo Praxis Company Details
  • 10.18.2 Grupo Praxis Business Overview
  • 10.18.3 Grupo Praxis Cell Therapy Introduction
  • 10.18.4 Grupo Praxis Revenue in Cell Therapy Business (2015-2020)
  • 10.18.5 Grupo Praxis Recent Development
• 13.19 Genzyme Corporation
  • 10.19.1 Genzyme Corporation Company Details
  • 10.19.2 Genzyme Corporation Business Overview
  • 10.19.3 Genzyme Corporation Cell Therapy Introduction
  • 10.19.4 Genzyme Corporation Revenue in Cell Therapy Business (2015-2020)
  • 10.19.5 Genzyme Corporation Recent Development
• 13.20 Advanced Tissue
  • 10.20.1 Advanced Tissue Company Details
  • 10.20.2 Advanced Tissue Business Overview
  • 10.20.3 Advanced Tissue Cell Therapy Introduction
  • 10.20.4 Advanced Tissue Revenue in Cell Therapy Business (2015-2020)
  • 10.20.5 Advanced Tissue Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer